Genprex (GNPX) Stock: Reprogramming The Course Of Cancer

Genprex GNPX Stock News

THE INTRO GENPREX, INC. (NASDAQ: GNPX) which is honoring its mission to REPROGRAMMING THE COURSE OF CANCER, is a clinical stage gene therapy approach company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogenic therapy for non-small cell lung cancer (NSCLC).  Genprex’s novel … Read more

Genprex (GNPX) Stock: Outlines The Opportunity In An Interview

Genprex Inc (NASDAQ: GNPX) is a stock that we’ve followed for some time at CNA Finance. Taking a unique approach to the treatment of cancer, the stock has caught the attention of the masses. Recently, the company’s CEO, Rodney Varner weighed in, in an interview with proactive investors. During the interview, Varner outlined the success … Read more

Genprex (GNPX) Stock: Running For The Top On Clinical Update

Genprex Inc (NASDAQ: GNPX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced a clinical update that clearly excited investors. Today, we’ll talk about: The update; what we’re seeing from the stock; and what we’ll be watching for with regard to GNPX ahead. GNPX Heads … Read more

Genprex (GNPX) Stock: Headed Up On Clinical And Corporate Update

Genprex Inc (NASDAQ: GNPX) is having a relatively strong start to the trading session this morning, and for good reason. The company provided a clinical and corporate update, leading to excitement among investors who are reacting by pushing the stock upward. Today, we’ll talk about: The update; what we’re seeing from GNPX as a result; … Read more